4//SEC Filing
Eiger BioPharmaceuticals, Inc. 4
Accession 0001209191-17-026909
CIK 0001305253operating
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 6:11 PM ET
Size
5.4 KB
Accession
0001209191-17-026909
Insider Transaction Report
Form 4
Glenn Jeffrey S
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-04-12+10,000→ 10,000 totalExercise: $8.50Exp: 2027-04-12→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 12 months measured from April 12, 2017 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeoperating
Related Parties
1- filerCIK 0001305253
Filing Metadata
- Form type
- 4
- Filed
- Apr 12, 8:00 PM ET
- Accepted
- Apr 13, 6:11 PM ET
- Size
- 5.4 KB